Mathematical modeling reveals the factors involved in the phenomena of cancer stem cells stabilization.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Cell Differentiation* ; Cell Proliferation* ; Models, Theoretical*; Neoplastic Stem Cells/*pathology; Humans

Cancer Stem Cells (CSC), a subset of cancer cells resembling normal stem cells with self-renewal and asymmetric division capabilities, are present at various but low proportions in many tumors and are thought to be responsible for tumor relapses following conventional cancer therapies. In vitro, most intriguingly, isolated CSCs rapidly regenerate the original population of stem and non-stem cells (non-CSCs) as shown by various investigators. This phenomenon still remains to be explained. We propose a mathematical model of cancer cell population dynamics, based on the main parameters of cell population growth, including the proliferation rates, the rates of cell death and the frequency of symmetric and asymmetric cell divisions both in CSCs and non-CSCs sub-populations, and taking into account the stabilization phenomenon. The analysis of the model allows determination of time-varying corridors of probabilities for different cell fates, given the particular dynamics of cancer cells populations; and determination of a cell-cell communication factors influencing these time-varying probabilities of cell behavior (division, transition) scenarios. Though the results of the model have to be experimentally confirmed, we can anticipate the development of several fundamental and practical applications based on the theoretical results of the model.
Competing Interests: The authors have declared that no competing interests exist.

Nature. 2006 Dec 7;444(7120):756-60. (PMID: 17051156)
Nat Med. 2011 Feb;17(2):211-5. (PMID: 21240262)
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14470-5. (PMID: 22908280)
Cell. 2008 May 16;133(4):704-15. (PMID: 18485877)
Cell Rep. 2017 Feb 28;18(9):2256-2268. (PMID: 28249169)
Cell Transplant. 2011;20(1):113-20. (PMID: 20887682)
Cell Stem Cell. 2013 May 2;12(5):602-15. (PMID: 23642368)
Nat Cell Biol. 2014 Mar;16(3):268-80. (PMID: 24561623)
Breast Cancer Res. 2007;9(4):109. (PMID: 17688678)
Blood Cells Mol Dis. 2004 Jan-Feb;32(1):17-20. (PMID: 14757407)
J Clin Oncol. 2008 Jun 10;26(17):2854-61. (PMID: 18539964)
Cell. 2009 Aug 21;138(4):645-659. (PMID: 19682730)
Nat Rev Cancer. 2005 Apr;5(4):275-84. (PMID: 15803154)
Nature. 2007 Jan 4;445(7123):111-5. (PMID: 17122771)
Cancer Res. 2008 Jun 1;68(11):4311-20. (PMID: 18519691)
Cancer Lett. 2013 Sep 10;338(1):10-4. (PMID: 22820159)
Bull Math Biol. 2009 Apr;71(3):602-26. (PMID: 19101772)
J R Soc Interface. 2014 Mar 12;11(94):20140079. (PMID: 24621818)
Cancer Res. 2013 Dec 15;73(24):7290-300. (PMID: 24142344)
Exp Hematol. 2004 Jan;32(1):25-7. (PMID: 14725897)
Cancer Res. 2015 Mar 15;75(6):940-9. (PMID: 25614516)
Sci Rep. 2013;3:2687. (PMID: 24045437)
PLoS One. 2019 Apr 22;14(4):e0215678. (PMID: 31009502)
PLoS One. 2013 Sep 03;8(9):e72847. (PMID: 24019882)
PLoS Comput Biol. 2015 Dec 23;11(12):e1004629. (PMID: 26700130)
J Clin Invest. 2014 Oct;124(10):4489-502. (PMID: 25202981)
Dev Biol. 2013 Jan 15;373(2):383-93. (PMID: 23110761)
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7950-5. (PMID: 21498687)
Int J Cancer. 2011 Nov 15;129(10):2328-36. (PMID: 21796620)
J Clin Oncol. 2008 Jun 10;26(17):2862-70. (PMID: 18539965)
Cell. 2009 Sep 18;138(6):1083-95. (PMID: 19766563)
Bull Math Biol. 2016 Dec;78(12):2304-2357. (PMID: 27324993)
Nat Commun. 2015 Feb 11;6:6139. (PMID: 25669750)
Curr Opin Hematol. 2004 Mar;11(2):81-7. (PMID: 15257023)
Cancer Res. 2006 Oct 1;66(19):9339-44. (PMID: 16990346)
Nature. 2001 Nov 1;414(6859):105-11. (PMID: 11689955)
J Clin Oncol. 2010 Sep 1;28(25):4006-12. (PMID: 20498387)
Cell Stem Cell. 2013 Jul 3;13(1):87-101. (PMID: 23827711)
PLoS Comput Biol. 2015 Mar 05;11(3):e1004025. (PMID: 25742563)
Cell. 2011 Aug 19;146(4):633-44. (PMID: 21854987)
Front Oncol. 2013 Apr 15;3:76. (PMID: 23596563)
J Natl Cancer Inst. 2006 Dec 20;98(24):1755-7. (PMID: 17179471)
J Theor Biol. 2017 Sep 21;429:190-203. (PMID: 28669884)
Nature. 2007 Jan 4;445(7123):106-10. (PMID: 17122772)
Cell Stem Cell. 2014 Mar 6;14(3):275-91. (PMID: 24607403)
Cell Stem Cell. 2012 Jun 14;10(6):717-728. (PMID: 22704512)
Stem Cells Dev. 2009 Apr;18(3):377-85. (PMID: 18752377)
Cancer Res. 2016 Apr 1;76(7):1705-13. (PMID: 26833122)
Sci Rep. 2018 Feb 12;8(1):2809. (PMID: 29434256)
J Theor Biol. 2007 Feb 7;244(3):367-74. (PMID: 17049944)
Cancer Res. 2007 Feb 1;67(3):1030-7. (PMID: 17283135)
Cytometry A. 2012 May;81(5):382-9. (PMID: 22407926)
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4008-13. (PMID: 17360468)

Date Created: 20191112 Date Completed: 20200316 Latest Revision: 20200316

20231215

PMC6844488

10.1371/journal.pone.0224787

31710617